What is NDC 63323-130?

63323-130 is the product NDC for Doxy 100 (doxycycline), Doxycycline hyclate 100 mg/10mL injection, powder, lyophilized, for solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Doxy 100?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Doxy 100 NDC 63323-130 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-130Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0130Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-130-13	6332301301363323013013	10 VIAL in 1 TRAY (63323-130-13) / 10 mL in 1 VIAL (63323-130-03)Marketed from Oct 17, 2000

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxy 100
Generic name (nonproprietary): doxycycline
Active ingredients: Doxycycline hyclate — 100 mg/10mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Fresenius Kabi USA, LLCNDC labeler code 63323
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 062475
Marketing start: Oct 17, 2000
Listing expires: Dec 31, 2027
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 63323-130_b4654993-19ce-4911-a0d0-4836f357223dSPL ID b4654993-19ce-4911-a0d0-4836f357223dSPL set ID b256babb-1bba-4b0c-8837-d13ba3af7659RxCUI 310027, 544840UNII 19XTS3T51UUPC 0363323130039
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323013013 followed by a unit qualifier and the quantity

Package 63323-0130-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 17, 2021.

Indications (excerpt from the label)

INDICATIONS AND USAGE: To reduce the development of drug-resistant bacteria and maintain the effectiveness of Doxycycline for Injection, USP and other antibacterial drugs, Doxycycline for Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Doxycycline for Injection, USP is indicated in infections caused by the following microorganisms: Rickettsia…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 63323-130

What is NDC 63323-130?: 63323-130 is the product NDC for Doxy 100 (doxycycline), Doxycycline hyclate 100 mg/10mL injection, powder, lyophilized, for solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Doxy 100 (Doxycycline).
What is the active ingredient?: Doxycycline hyclate.
Who is the labeler?: Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Doxy 100?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 062475

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 062475
Product	Strength	Form · route	Labeler	Product NDC
Doxy 100(Tm) Doxycycline	Doxycycline hyclate 100 mg/10mL	Injection, Powder, Lyophilized, For solutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1402

Doxy 100 (Doxycycline) NDC 63323-130